NIPRUSS 60 mg clinical trials

The effect of empagliflozin on peripheral microvascular dysfunction in heart failure with preserved ejection fraction

This study for people with a type of heart failure called 'heart failure with preserved ejection fraction' is looking at how a medicine called empagliflozin affects tiny blood vessels in the skin. We want to see if it improves blood flow.